Controversy about the Role of Rifampin in Biofilm Infections: Is It Justified?

Lower Success Rate of Débridement and Implant Retention in Late Acute versus Early Acute Periprosthetic Joint Infection Caused by Staphylococcus spp. Results from a Matched Cohort Study

(2020) Marjan Wouthuyzen-Bakker et al.   CLINICAL ORTHOPAEDICS AND RELATED RESEARCH

In vitro activity of TNP-2092 against periprosthetic joint infection–associated staphylococci

(2020) Cody R. Fisher et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Adjunctive rifampin for the treatment of Staphylococcus aureus bacteremia with deep infections: A meta-analysis

(2020) Huan Ma et al.   PLoS One

Rifabutin Use in Staphylococcus Biofilm Infections: A Case Series

(2020) James B. Doub et al.   Antibiotics-Basel

Rifampin combination therapy in staphylococcal prosthetic joint infections: a randomized controlled trial

(2020) Øystein Espeland Karlsen et al.   Journal of Orthopaedic Surgery and Research

A standardized interdisciplinary algorithm for the treatment of prosthetic joint infections

(2019) D. Karczewski et al.   Bone & Joint Journal

The Benefice of Mobile Parts’ Exchange in the Management of Infected Total Joint Arthroplasties with Prosthesis Retention (DAIR Procedure)

(2019) Stefanie Hirsiger et al.   Journal of Clinical Medicine

In vitro Activity of Rifampin, Rifabutin, Rifapentine and Rifaximin Against Planktonic and Biofilm States of Staphylococci Isolated from Periprosthetic Joint Infection

(2019) Mariana Albano et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Analysis of postoperative and hematogenous prosthetic joint-infection microbiological patterns in a large cohort

(2018) Valérie Zeller et al.   JOURNAL OF INFECTION

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial

(2018) Guy E Thwaites et al.   LANCET

Non-compliance with IDSA guidelines for patients presenting with methicillin-susceptible Staphylococcus aureus prosthetic joint infection is a risk factor for treatment failure

(2018) A. Bouaziz et al.   MEDECINE ET MALADIES INFECTIEUSES

Should we expand the indications for the DAIR (debridement, antibiotic therapy, and implant retention) procedure for Staphylococcus aureus prosthetic joint infections? A multicenter retrospective study

(2018) O. Lesens et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Clinical outcome and risk factors for failure in late acute prosthetic joint infections treated with debridement and implant retention

(2018) Marjan Wouthuyzen-Bakker et al.   JOURNAL OF INFECTION

The Role of Rifampin against Staphylococcal Biofilm Infections in Vitro, in Animal Models, and in Orthopedic Device-Related Infections.

(2018) Werner Zimmerli et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Debridement and implant retention in the management of hip periprosthetic joint infection

(2017) P. Sendi et al.   Bone & Joint Journal

Validation of a treatment algorithm for orthopaedic implant-related infections with device-retention—results from a prospective observational cohort study

(2016) S. Tschudin-Sutter et al.   CLINICAL MICROBIOLOGY AND INFECTION

Short- versus long-duration levofloxacin plus rifampicin for acute staphylococcal prosthetic joint infection managed with implant retention: a randomised clinical trial

(2016) Jaime Lora-Tamayo et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Rifamycins, Alone and in Combination

(2016) David M. Rothstein   Cold Spring Harbor Perspectives in Medicine

Polyethylene Insert Exchange Is Crucial in Debridement for Acute Periprosthetic Infections following Total Knee Arthroplasty

(2016) Chaofan Zhang et al.   Journal of Knee Surgery

75% success rate after open debridement, exchange of tibial insert, and antibiotics in knee prosthetic joint infections

(2015) Anna Holmberg et al.   Acta Orthopaedica

Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications

(2015) Larry M. Baddour et al.   CIRCULATION

Predictors of treatment outcome in prosthetic joint infections treated with prosthesis retention

(2015) Ari-Pekka Puhto et al.   INTERNATIONAL ORTHOPAEDICS

High Activity of Fosfomycin and Rifampin against Methicillin-Resistant Staphylococcus aureus Biofilm In Vitro and in an Experimental Foreign-Body Infection Model

(2014) R. Mihailescu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Factors predictive of treatment failure in staphylococcal prosthetic vascular graft infections: a prospective observational cohort study: impact of rifampin

(2014) Laurence Legout et al.   BMC INFECTIOUS DISEASES

Surgical and Antimicrobial Treatment of Prosthetic Vascular Graft Infections at Different Surgical Sites: A Retrospective Study of Treatment Outcomes

(2014) Stefan Erb et al.   PLoS One

Activity of dalbavancin, alone and in combination with rifampicin, against meticillin-resistant Staphylococcus aureus in a foreign-body infection model

(2013) Daniela Baldoni et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of America

(2012) D. R. Osmon et al.   CLINICAL INFECTIOUS DISEASES

A Large Multicenter Study of Methicillin–Susceptible and Methicillin–Resistant Staphylococcus aureus Prosthetic Joint Infections Managed With Implant Retention

(2012) Jaime Lora-Tamayo et al.   CLINICAL INFECTIOUS DISEASES

Outcome and Predictors of Treatment Failure in Total Hip/Knee Prosthetic Joint Infections Due to Staphylococcus aureus

(2011) E. Senneville et al.   CLINICAL INFECTIOUS DISEASES

Short-course antibiotics for prosthetic joint infections treated with prosthesis retention

(2011) A.-P. Puhto et al.   CLINICAL MICROBIOLOGY AND INFECTION

Can Implant Retention be Recommended for Treatment of Infected TKA?

(2010) Ho-Rim Choi et al.   CLINICAL ORTHOPAEDICS AND RELATED RESEARCH

Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention

(2010) O. C. Helou et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Fatal bacteraemia and infective endocarditis due to meticillin-resistant Staphylococcus aureus (MRSA) with rapid emergence of rifampicin resistance during vancomycin/rifampicin combination treatment

(2010) Wei-Lun Liu et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

A rifampicin-containing antibiotic treatment improves outcome of staphylococcal deep sternal wound infections

(2010) B. Khanlari et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

EMERGENCE OF RIFAMPICIN RESISTANCE DURING RIFAMPICIN-CONTAINING TREATMENT IN ELDERLY PATIENTS WITH PERSISTENT METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS BACTEREMIA

(2010) Chih-Cheng Lai et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Efficacy of Daptomycin in Implant-Associated Infection Due to Methicillin-Resistant Staphylococcus aureus: Importance of Combination with Rifampin

(2009) A.-K. John et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Addition of Rifampin to Standard Therapy for Treatment of Native Valve Infective Endocarditis Caused by Staphylococcus aureus

(2008) D. J. Riedel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Linezolid Alone or Combined with Rifampin against Methicillin-Resistant Staphylococcus aureus in Experimental Foreign-Body Infection

(2008) D. Baldoni et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Adjunctive Use of Rifampin for the Treatment of Staphylococcus aureus Infections

(2008) Joshua Perlroth et al.   ARCHIVES OF INTERNAL MEDICINE